Sold as Phenergan Vc W/ Codeine. Every FDA application for this active ingredient: 1 branded and 7 generic.
As of Nov 16, 2026, FDA lists 8 applications for Codeine Phosphate; Phenylephrine Hydrochloride; Promethazine Hydrochloride (sold as Phenergan Vc W/ Codeine), first approved Jan 21, 1952, with 1 new use approved and 0 published complete response letters.
| Jan 21, 1952 | Phenergan W/ Codeine, Phenergan Vc W/ CodeineNDA 8306 ยท New combination | Ani Pharms | 23 | Discontinued |
| Oct 31, 1984 | Prometh Vc W/ CodeineANDA 88764 | Chartwell Rx | 51 | Discontinued |
| Jan 4, 1985 | Promethazine Vc W/ CodeineANDA 88896 | Wockhardt | 11 | Discontinued |
| Nov 22, 1985 | Promethazine Vc W/ CodeineANDA 88816 | Cenci | 4 | Discontinued |
| Mar 2, 1987 | Pherazine Vc W/ CodeineANDA 88870 | Halsey | 1 | Discontinued |
| Dec 7, 2006 | Prometh Hydrochloride,Phenylephrine Hydrochloride W/Codeine PhosphateANDA 40660 | Pai Holdings | 12 | Marketed |
| Dec 23, 2014 | Promethazine Hydrochloride, Phenylephrine Hydrochloride W/Codeine PhosphateANDA 40674 | Hikma | 7 | Discontinued |
| Aug 26, 2015 | Promethazine Hydrochloride,Phenylephrine Hydrochloride W/Codeine PhosphateANDA 200963 | Amneal Pharms | 7 | Marketed |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA